Procter & Gamble Health Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: PGHL BSE: 500126 BSE: 533081

₹5563.00

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #46 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Procter & Gamble Health Limited (this stock)	9,234	25.9	62.3%	-11.7%	2.79%	99	18	66

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹9,057 Cr

EV / EBITDA

17.6x

EV / Sales

6.32x

Market cap / Sales

6.44x

Earnings yield

3.86%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 368 Cr, up 7.2% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 96 Cr, up 45.3% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	364	129	96	₹57.9200
March 31, 2026	370	133	95	₹56.9900
Dec. 31, 2025	374	109	78	₹46.7400
Sept. 30, 2025	325	119	89	₹53.3400
June 30, 2025	339	89	66	₹39.8700
March 31, 2025	311	79	61	₹
Dec. 31, 2024	310	122	91	₹54.7600
Sept. 30, 2024	313	111	82	₹49.6000
June 30, 2024	284	23	17	₹10.1100
March 31, 2024	252	63	47	₹28.0000
Dec. 31, 2023	310	100	72	₹43.4000
Sept. 30, 2023	305	88	66	₹39.5000
June 30, 2023	301	44	30	₹17.9600

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	368	374	378	330	343	314	317	286	255	315	311	307	326
Operating revenue	364	370	374	325	339	310	313	284	252	310	305	301	321
Other income	4	4	4	5	4	4	3	2	2	5	6	5	5
Operating expenses	264	235	263	205	248	186	199	236	185	208	216	256	243
Operating profit	100	136	110	120	90	123	114	48	67	102	89	45	78
Operating profit margin	27.4%	36.6%	29.5%	37.0%	26.7%	39.8%	36.4%	17.0%	26.7%	32.8%	29.1%	15.0%	24.2%
Depreciation	6	6	6	6	5	6	6	7	7	7	6	6	4
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	32	—	—	—	—	—	—	-20	—	—	—	—	—
Profit before tax	129	133	109	119	89	122	111	23	63	100	88	44	79
Tax	33	39	31	30	23	31	29	6	16	28	22	14	19
Net profit	96	95	78	89	66	91	82	17	47	72	66	30	59
EPS	57.92	56.99	46.74	53.34	39.87	54.76	49.60	10.11	28.00	43.40	39.50	17.96	35.70
Net profit (TTM)	357	327	323	328	256	237	218	201	214	227	231	229	241
EPS (TTM)	214.99	196.94	194.71	197.57	154.34	142.47	131.11	121.01	128.86	136.56	139.46	138.26	145.10

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	1,408	450	327
March 31, 2025	934	312	234
March 31, 2024	867	250	184
March 31, 2023	928	270	200

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	14.7%	8.4%	1,425^†	—	886^†	944^†	1,116^†	951^†	964^†	919^†	1,206^†	1,041^†
Operating revenue	14.9%	8.8%	1,408	934	867	928	1,104^†	924^†	924^†	882^†	1,184^†	1,015^†
Other income	—	—	17^†	—	19^†	16^†	13^†	26^†	41^†	37^†	23^†	26^†
Operating expenses	—	—	951^†	—	866^†	886^†	847^†	—	—	—	—	—
Operating profit	120.5%	—	457^†	—	2^†	43^†	257^†	—	—	—	—	—
Operating profit margin	—	—	32.4%^†	—	0.2%^†	4.6%^†	23.3%^†	—	—	—	—	—
Depreciation	—	—	24^†	—	27^†	29^†	27^†	31^†	17^†	18^†	29^†	—
Interest	—	—	1^†	—	1^†	1^†	1^†	—	—	—	—	—
Exceptional items, gain / (loss)	—	—	0^†	—	0^†	0^†	0^†	0^†	0^†	0^†	24^†	0^†
Profit before tax	18.5%	12.9%	450	312	250	270	242^†	245^†	236^†	193^†	174^†	117^†
Tax	—	—	123^†	—	81^†	84^†	57^†	54^†	71^†	65^†	72^†	38^†
Net profit	17.9%	11.3%	327	234	184	200	185^†	192^†	165^†	—	102^†	78^†
EPS	10.7%	11.3%	196.94^†	—	128.86^†	145.10^†	111.60^†	115.50^†	99.11^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	32.4%^†	—	0.2%^†	4.6%^†	23.3%^†	—	—	—	—	—
EBIT margin	32.0%^†	—	29.0%^†	29.2%^†	22.0%^†	—	—	—	—	—
PBT margin	32.0%	33.4%	28.9%	29.1%	21.9%^†	26.6%^†	25.5%^†	21.9%^†	14.7%^†	11.5%^†
Net margin	23.2%	25.1%	21.2%	21.5%	16.8%^†	20.7%^†	17.8%^†	—	8.6%^†	7.7%^†
Interest coverage	818.93x^†	—	364.03x^†	436.60x^†	426.07x^†	—	—	—	—	—
Dividend payout	78.7%^†	—	77.6%^†	67.2%^†	35.8%^†	36.4%^†	419.7%^†	—	—	—
Earnings retention	21.3%^†	—	22.4%^†	32.8%^†	64.2%^†	63.6%^†	-319.7%^†	—	—	—
Current ratio	2.18x	2.44x	—	—	—	—	—	—	—	—
Quick ratio	1.65x	1.94x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	0.00x	—	—	—	—	—	—	—	—
Return on equity	62.3%	43.7%	—	—	—	—	—	—	—	—
Return on assets	38.9%	29.5%	—	—	—	—	—	—	—	—
Return on capital employed	76.8%^†	—	—	—	—	—	—	—	—	—
Asset turnover	1.67x	1.18x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	338	1	-344	16	322
March 31, 2025	169	10	-235	0	169

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	841	525	508	0	0	556	255	177	99	137
March 31, 2025	794	537	520	0	0	526	215	182	105	109

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.